Psychometric Properties of the Persian Self-Advocacy in Cancer Survivorship Scale (SACS-P) in Iran [0.03%]
伊朗癌症幸存者自我倡导量表（SACS-P）的 psychometric特性
Elaheh Habibpour,Nargess Ramazanzadeh,Sevda Gardashkhani et al.
Elaheh Habibpour et al.
Background: Self-advocacy is crucial for cancer patients, as it allows them to express their needs and engage in treatment decisions. This skill enhances the quality of care and life satisfaction. Accurately measuring sel...
Association Between Body Roundness Index and Cancer Risk, With Further Stratification by Cardiometabolic Disease Status: Findings From Three National Longitudinal Cohorts [0.03%]
基于三项全国性队列研究的分析：身体圆度指数与癌症风险的关系及其在心血管代谢性疾病状态下的进一步分层分析
Pincheng Luo,Yanxue Lian
Pincheng Luo
Objective: This study investigates the association between body roundness index (BRI) and overall cancer incidence in a large population-based cohort and explores the consistency of this association in individuals with an...
BUB1B Promotes Ovarian Cancer Cell Proliferation and Metastasis by Activating the Wnt/β-Catenin Pathway [0.03%]
BUB1B通过激活Wnt/β-catenin途径促进卵巢癌细胞增殖和转移
Jing Wang,Xiaoling Su,Nan Lin et al.
Jing Wang et al.
Background: BUB1 mitotic checkpoint serine/threonine kinase B (BUB1B) has been found to participate in cancer progression. Nevertheless, the function and mechanism of BUB1B in ovarian cancer (OC) remain unknown. ...
Investigating Genomic Differences by Ethnicity in Breast, Colorectal and Prostate Cancers: Secondary Data Analysis of the Genomic Data Commons (GDC) Database [0.03%]
基于GDC数据库的乳腺癌、结直肠癌和前列腺癌种族差异的基因组研究：二次数据分析
Jack Carr,Mark A Faghy,David Broom et al.
Jack Carr et al.
Objective: Globally, millions of cancer cases are diagnosed annually and mortality rates continue to rise with breast (BC), colorectal (CRC) and prostate (PC) cancer among the most prevalent. Race and ethnic disparities i...
Molecular Characteristics and Treatment Implications of TP53 Gain-of-Function Mutations in Non-Small Cell Lung Cancer [0.03%]
非小细胞肺癌TP53获得性功能突变的分子特征及其治疗意义
Zheng Zhao,Rui Lu,Feng Zhang et al.
Zheng Zhao et al.
Background: TP53 gain-of-function (GOF) effects lead to cellular responses beyond the capabilities of wild-type TP53 and are known to promote cancer progression, resulting in poorer outcomes in cancer. ...
BTK Inhibitor Synergizes With CD19-Targeted Chimeric Antigen Receptor-T Cells in Patients With Relapsed or Refractory B-Cell Lymphoma: An Open-Label Pragmatic Clinical Trial [0.03%]
B细胞淋巴瘤患者的BTK抑制剂与CD19靶向嵌合抗原受体T细胞临床试验：开放标签务实型临床试验
Wenjing Luo,Yinqiang Zhang,Chenggong Li et al.
Wenjing Luo et al.
Background: CD19-targeted chimeric antigen receptor-T cell (CART19) therapy is clinically effective in patients with relapsed or refractory B-cell lymphoma (BCL), but treatment failure and recurrence need to be overcome. ...
The Invisible Costs of Cancer Treatment: Quantifying Non-Medical Economic Consequences for Cancer Survivors Undergoing Systemic and Radiation Therapies [0.03%]
癌症治疗的隐形成本——量化全身和放射治疗的癌症幸存者的非医疗经济后果
Md Shahjalal,Padam Kanta Dahal,Md Parvez Mosharaf et al.
Md Shahjalal et al.
Background: The non-medical economic consequences of cancer on individuals and families in low- and middle-income countries, including Bangladesh, remain poorly quantified. This study measures the non-medical economic con...
Nanoliposomal Irinotecan in Combination With 5-Fluorouracil and Leucovorin for Advanced Head and Neck and Esophageal Squamous Cell Carcinoma After Prior Platinum-Based Chemotherapy or Chemoradiotherapy: A Multicenter Phase II Trial [0.03%]
联合使用纳诺脂质体伊立替康、氟尿嘧啶和亚叶酸钙治疗经铂类化疗或放化疗失败的晚期头颈部及食管鳞癌：一项多中心Ⅱ期临床试验
Muh-Hwa Yang,Shang-Yin Wu,I-Wei Ho et al.
Muh-Hwa Yang et al.
Purpose: To evaluate the efficacy and safety of nanoliposomal irinotecan (nal-IRI) plus 5-fluorouracil (5-FU) and leucovorin (LV) in patients with platinum-refractory or intolerant head and neck squamous cell carcinoma (H...
Clinical Trial
Cancer medicine. 2025 Oct;14(20):e71307. DOI:10.1002/cam4.71307 2025
Clinical Features and Outcomes of Primary Colorectal Diffuse Large B-Cell Lymphoma: A Multicenter Retrospective Study [0.03%]
原发性结直肠弥漫大B细胞淋巴瘤的临床特点和结局：多中心回顾性研究
Yong-Pyo Lee,Myung-Won Lee,Seonggyu Byeon
Yong-Pyo Lee
Background: Primary gastrointestinal (GI) diffuse large B-cell lymphoma (DLBCL) is a rare malignancy. Given its rarity, the nature of the disease, particularly those originating in the colorectum, remains poorly defined. ...
Multicenter Study
Cancer medicine. 2025 Oct;14(20):e71313. DOI:10.1002/cam4.71313 2025